Quads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma

(MedPage Today) -- Using quadruplet regimens with anti-CD38 monoclonal antibodies, such as daratumumab (Darzalex) or isatuximab (Sarclisa), has significantly advanced frontline therapy for both transplant-eligible and transplant-ineligible patients...